JPS58501675A - 物質ｐ「きつ」抗質からなる薬材 - Google Patents

物質ｐ「きつ」抗質からなる薬材

Info

Publication number
JPS58501675A
JPS58501675A JP50331281A JP50331281A JPS58501675A JP S58501675 A JPS58501675 A JP S58501675A JP 50331281 A JP50331281 A JP 50331281A JP 50331281 A JP50331281 A JP 50331281A JP S58501675 A JPS58501675 A JP S58501675A
Authority
JP
Japan
Prior art keywords
substance
pro2
prophylactically
trp7
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50331281A
Other languages
English (en)
Japanese (ja)
Inventor
ハカンソン・ロルフ
ヘリグ・ヨアヒム
Original Assignee
フエ−リング・ア−ベ−
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フエ−リング・ア−ベ− filed Critical フエ−リング・ア−ベ−
Publication of JPS58501675A publication Critical patent/JPS58501675A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP50331281A 1981-10-09 1981-10-09 物質ｐ「きつ」抗質からなる薬材 Pending JPS58501675A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1981/000292 WO1983001252A1 (fr) 1981-10-09 1981-10-09 Medicament a base d'un antagoniste de la substance p

Publications (1)

Publication Number Publication Date
JPS58501675A true JPS58501675A (ja) 1983-10-06

Family

ID=20342922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50331281A Pending JPS58501675A (ja) 1981-10-09 1981-10-09 物質ｐ「きつ」抗質からなる薬材

Country Status (5)

Country Link
EP (1) EP0090798A1 (fr)
JP (1) JPS58501675A (fr)
BE (1) BE894602A (fr)
IT (1) IT1191028B (fr)
WO (1) WO1983001252A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07304649A (ja) * 1994-05-05 1995-11-21 L'oreal Sa 化粧品組成物においてサブスタンスｐアンタゴニストを使用する使用方法およびその組成物
JPH09110658A (ja) * 1995-09-19 1997-04-28 L'oreal Sa サブスタンスｐアンタゴニストを含有するケラチン繊維染色用組成物

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001772A1 (fr) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Composition de cyclosporine oculaire
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
FR2719476B1 (fr) * 1994-05-05 1997-05-23 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
FR2728265A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p dans une composition pharmaceutique
FR2732598B1 (fr) 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038546A (fr) * 1973-06-27 1975-04-10
US4052325A (en) * 1974-12-23 1977-10-04 Eastman Kodak Company Liquid electrographic developer composition containing redispersible polyester toner and process
JPS5425833A (en) * 1977-07-29 1979-02-27 Canon Inc Electrophotography
JPS54149794A (en) * 1978-05-15 1979-11-24 Eastman Kodak Co Novel polyester * and novel developing solution for electrography containing it
JPS5725832A (en) * 1980-07-23 1982-02-10 Olympus Optical Co Light source apparatus for endoscope

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038546A (fr) * 1973-06-27 1975-04-10
US4052325A (en) * 1974-12-23 1977-10-04 Eastman Kodak Company Liquid electrographic developer composition containing redispersible polyester toner and process
JPS5425833A (en) * 1977-07-29 1979-02-27 Canon Inc Electrophotography
JPS54149794A (en) * 1978-05-15 1979-11-24 Eastman Kodak Co Novel polyester * and novel developing solution for electrography containing it
JPS5725832A (en) * 1980-07-23 1982-02-10 Olympus Optical Co Light source apparatus for endoscope

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07304649A (ja) * 1994-05-05 1995-11-21 L'oreal Sa 化粧品組成物においてサブスタンスｐアンタゴニストを使用する使用方法およびその組成物
JPH09110658A (ja) * 1995-09-19 1997-04-28 L'oreal Sa サブスタンスｐアンタゴニストを含有するケラチン繊維染色用組成物

Also Published As

Publication number Publication date
BE894602A (fr) 1983-01-31
IT8223678A1 (it) 1984-04-08
IT8223678A0 (it) 1982-10-08
WO1983001252A1 (fr) 1983-04-14
IT1191028B (it) 1988-02-24
EP0090798A1 (fr) 1983-10-12

Similar Documents

Publication Publication Date Title
AU714846B2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
US5028592A (en) Antipyretic and anti-inflammatory peptides
US5157023A (en) Antipyretic and anti-inflammatory lys pro val compositions and method of use
US5545719A (en) Nerve growth peptides
JPH06293659A (ja) 環式付着阻害剤
WO2009094850A1 (fr) Protéine immunomodulatrice recombinante de reishi (ganoderma lucidium) (rlz-8) et ses utilisations
KR20150037815A (ko) 산소 부족 및 공기압 감소에 인한 고산병의 폐 형태의 치료를 위한 약학 조성물
CN113491763B (zh) 眼镜蛇神经毒素及其制剂在制备预防和/或治疗帕金森病的药物中的应用
JPH02504277A (ja) 胃腸潰瘍疾患の治療のためのプロテイナーゼインヒビター
CN116003530B (zh) 一种针对白细胞介素-6的d-蛋白抑制剂及其应用
CA2515033C (fr) Peptide clk et peptide slk
US5411943A (en) Hepatoma treatment with somatostatin analogs
EP0090798A1 (fr) Medicament a base d'un antagoniste de la substance p
US4390528A (en) Tuftsinyl-tuftsin
AU2004225986B2 (en) STQ-peptides
CN113929761A (zh) 新型生长激素释放激素类似肽改构和二聚体化制备及其应用
Mochiki et al. Exogenous motilin stimulates endogenous release of motilin through cholinergic muscarinic pathways in the dog
WO1992020362A1 (fr) Peptides favorisant le developpement de cellules nerveuses et leurs utilisations
JPS60231618A (ja) 胃腸潰瘍の治癒促進用製剤組成物
CN116135876B (zh) 一种多肽及其在制备抗肿瘤药物中的用途
JPH11510794A (ja) 初乳由来成長因子
CN118126198A (zh) Dav及其在制备恶性黑色素瘤药物中的应用
CN117683094A (zh) 一种硬骨素结合环肽及其应用
CN115073553A (zh) 一种选择性tnfr1拮抗肽sn61-4g及其在炎症性肠病中的应用
JP2003522196A (ja) 潰瘍性大腸炎およびその関連疾患の治療方法および診断方法